Effect of snuff and smoking on tenascin expression in oral mucosa

Journal of Oral Pathology and Medicine

Volumn 26, Issue 7, 1997, Pages 334-338

  Luomanen, Marita ^a,e   Tiitta, Outi ^a   Heikinheimo, Kristiina ^b   Leimola Virtanen, Riitta ^c   Heinaro, Ilkka ^d   Happonen, Risto Pekka ^c  

^a Institute of Biomedicine   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d Finnish Student Health Service   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Epithelial mesenchymal interaction; Mouth mucosa; Snuff; Tenascin; Tobacco

Indexed keywords

EID: 0031214335     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1997.tb00225.x     Document Type: Article

References (48)

1. ANDERSSON G, AXÉLL T. Clinical appearance of lesions associated with the use of loose can packed and portion-bag packed Swedish moist snuff - a comparative study. J Oral Pathol Med 1989; 18: 2-7.
2. PINDBORG JJ, POULSEN HE. Studies on oral leukoplakias. I. The influence of snuff upon the connective tissue of the oral mucosa. Prelimmary report. Acta Pathol Microbiol Scand 1962; 55: 412-4.
3. PINDBORG JJ, RENSTRUP G. Studies in oral leukoplakias. II. Effect of snuff on oral epithelium. Acta Derm Venereol 1963; 43: 271-6.
4. PINDBORG JJ, REIBEL J, ROED-PETERSEN B, MEHTA FS. Tobacco-induced changes in oral leukoplakia epithelium. Cancer 1980; 45: 2330-6.
5. GREER RO, POULSON TC. Oral tissue alterations associated with the use of smokeless tobacco by teen-agers. Oral Surg Oral Med Oral Pathol 1983; 56: 275-84.
6. KAUGARS GE, MEHAILESCU WL, GUNSOLLEY JC. Smokeless tobacco use and oral epithelial dysplasia. Cancer 1989; 64; 1527-30.
7. ANDERSSON G. Snuff-induced changes associated with the use of loose and portion-bag-packed Swedish moist snuff. Swedish Dent J 1991; Suppl 75: 1-55.
8. AXÉLL T, MÖRNSTAD H, SUNDSTRÖM B. The relation of the clinical picture to the histopathology of snuff dipper's lesions in a Swedish population. J Oral Pathol 1976; 5: 229-36.
9. HIRSCH J-M, HEYDEN G, THILANDER H. A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity. J Oral Pathol 1982; 11: 387-98,
10. ANDERSSON G, AXÉLL T, LARSSON Å. Impact of consumption factors on soft tissue changes in Swedish moist snuff users - a histologic study. J Oral Pathol Med 1990; 19: 453-8.
11. PEACOCK EE, GREENBERG BG, BRAWLEY BW. The effect of snuff and tobacco on the production of oral carcinoma: an experimental and epidemiological study. Ann Surg 1960; 151: 542-50.
12. WINN DM, BLOT WJ, SHY CM, PICKLE LW, TOLEDO A, FRAUMENI JF. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981; 304: 745-9.
13. BOYD NM, READE PC. Mechanisms of carcinogenesis with particular reference to the oral nmcosa. J Oral Pathol 1988; 17: 193-201.
14. CHIQUET-EHRISMANN R. What distinguishes tenascin from fibronectin? FASEB J 1990; 4: 2598-604.
15. ERICKSON HP, BOURDON MA. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 1989; 5: 71-92.
16. KOUKOULIS GK, GOULD VE, BHATTACHARYYA A, GOULD JE, HOWEEDY AA, VIRTANEN I, Tenascin in normal, reactive, hyperplastic and neoplastic tissues: biologic and pathologic implications. Hum Pathol 1991; 22: 636-43.
17. NATALI PG, WICOTRA MR, BIGOTTI A, et al. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal. adult and tumor tissues. Int J Cancer 1991; 47: 811-6.
18. MACKIE EJ, HALFTER W, LIVERANI D. Induction of tenascin in healing wounds. J Cell Biol 1988; 107: 2757-67.
19. ASSAD L, SCHWARTZ MM, VIRTANEN I, GOULD VE. Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies. Virchows Archiv B Cell Pathol 1993; 63; 307-16.
20. LUOMANEN M, VIRTANEN I. Distribution of tenascin in healing, incision, excision and laser wounds. J Oral Pathol Med 1993; 22; 41-5.
21. MCCAHREN SS, LIGHTNER VA. Expression of human tenascin in synovitis and its regulation by interleukin-1. Arthritis Rheum 1992; 35: 1185-96.
22. TIITTA O, HAPPONEN RP, VIRTANEN I, LUOMANEN M. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma. J Oral Pathol Med 1994; 23: 446-50.
23. ANBAZHAGAN R, SAKAKURA T, GUSTERSON BA. The distribution of immunoreactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia. Virchows Archiv B Cell Pathol 1990; 59: 59-63.
24. SCHALKWIJK J, STEIJLEN PM, VAN VLIJMEN-WILLEMS IMJJ, OOSTERLING B, MACKIE EJ, VERSTRAETEN AA. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991; 139: 1143-50.
25. SCHALKWIJK J, VAN VLIJMEN I, OUSTERLING B, et al. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991; 124: 13-20.
26. STEIJLEN PM, MAESSEN E, KRESSE H, et al. Expression of tenascin, biglycan and decorin in disorders of keratinization. Br J Dermatol 1994; 130: 564-8.
27. CHIQUET-EHRISMANN R, MACKIE EJ, PEARSON CA, SAKAKURA T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47: 131-9.
28. EKBLOM P, AUFDERHEIDE E. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int J Dev Biol 1989; 33: 71-9.
29. PRIETO AL, JONES FS, CUNNINGHAM BA, CROSSIN KL, EDELMAN GM. Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization. J Cell Biol 1990; 111: 685-98.
30. ONDA H, POULIN ML, TASSAVA RA, CHIU I-M. Characterization of a newt tenascin cDNA and localization of tenascin mRNA during newt limb regeneration by in situ hybridization. Dev Biol 1991; 148: 219-32.
31. AUFDERHEIDE E, CHIQUET-EHRISMANN R, EKBLOM P. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 1987; 105: 599-608.
32. INAGUMA Y, KUSAKABE M, MACKIE EJ, PEARSON CA, CHIQUET-EHRISMANN R, SAKAKURA T. Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol 1988; 128: 245-55.
33. THESLEFF I, MACKIE E, VAINIO S, CHIQUET-EHRISMANN R. Changes in the distribution of tenascin during tooth development. Development 1987; 101: 289-96.
34. BRISTOW J, TEE MK, GITELMAN SE, MELLON SH, MILLER WL. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 1993; 122: 265-78.
35. ERICKSON HP. Tenascin-C, tenascin-R and tenascin X: a family of talented proteins in search of functions Curr Opin Cell Biol 1993; 5: 869-76.
36. TITTA O. Tenascin expression in preneoplastic and neoplastic lesions and in inflammatory conditions. An immunohistochemical study on cervical, gastric, urinary bladder and oral lesions using a monoclonal antibody. Thesis, University of Helsinki, 1995.
37. LUOMANEN M, TIITTA O, HEIKINHEIMO K, HEINARO I, HAPPONEN R-P. Effect of smokeless tobacco on the cytokeratin expression of oral sulcular mucosa. J Oral Pathol Med 1997; 26: 110-6.
38. ANDERSSON G, AXÉLL T, LARSSON Å. Histologic changes associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J Oral Pathol Med 1989; 18: 491-7.
39. TIITTA O, WAHLSTRÖM T, PAAVONEN J, et al. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Am J Pathol 1992; 141: 907-13.
40. HOWEEDY AA, VIRTANEN I, LAITINEN L, GOULD NS, KOUKOULIS GK, GOULD VE. Differential distribution of tenascin in the normal, hyperplastic and neoplastic breast. Lab Invest 1990; 63: 798-806.
41. BECKER J, SCHUPPAN D, MÜLLER S. The immunohistochemical distribution of collagens type I, III, IV and VI, of undulin and of tenascin in oral fibrous hyperplasia. J Oral Pathol Med 1993; 22: 463-7.
42. VAIDYA MM, BORGES AM, PRADHAN SA, RAJPAL RM, BHISEY AN. Altered keratin expression in buccal mucosal squamous cell carcinoma. J Oral Pathol Med 1989; 18: 282-6.
43. RÜEGG CR, CHIQUET-EHRISMANN R, ALKAN SS. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 1989; 86: 7437-41
44. HEMESATH TJ, MARTON LS, STEFANSSON K. Inhibition of T cell activation by the extracellular matrix protein tenascin. J Immunol 1994; 152: 5199-207.
45. CHEVALIER X, GROULT N, LARGET-PIET B, ZARDI L, HORNEBECK W. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1994; 37: 1013-22.
46. KNAGGS HE, LAYTON AM, MORRIS C, WOOD EJ, HOLLAND DB, CUNLIFFE WJ Investigation of the expression of the extracellular matrix glycoproteins tenascin and fibronectin during acne vulgaris. Br J Dermatol 1994; 130: 576-82.
47. TIITTA O, LUOMANEN M, HIETANEN J, VIRTANEN I. Tenascin expression in mucocutaneous diseases and related lesions of oral mucosa. Arch Oral Biol 1995; 40: 1039-45.
48. LEIMOLA-VIRTANEN R, SYRJÄNEN S, HAPPONEN R-P, VIRTANEN I, LUOMANEN M. Lack of effect of hormonal treatment and smoking on cytokertin expression in buccal mucosa. J Oral Pathol Med 1995; 24: 251-4.